LONDON, Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased ...
Smith& Nephew’s Advanced Wound Management division recently announced the U.S.launch of its new Renasys EZ negative pressure wound therapy system. The new productwill enable clinicians to exercise ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a ...
The Food & Drug Administration has approved Smith & Nephew’s PICO wound care system, the company announced. The pocket-sized Negative Pressure Wound Therapy (NPWT) system is indicated for pressure and ...
This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized ...
LONDON, Aug 1 (Reuters) - Artificial knee and hip maker Smith & Nephew reported trading profit of $232 million on Thursday, up 1 percent on an underlying basis, as strength in its advanced wound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback